- Home
- BCG vs NTRB Comparison
BCG vs NTRB Comparison
Compare BCG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCG | NTRB |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 71.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BCG | NTRB |
|---|---|---|
| Price | $2.46 | $4.69 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 40.9K | 19.6K |
| Earning Date | 11-13-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $178,203,000.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $64.21 | ★ N/A |
| Revenue Growth | 10.19 | ★ 12.69 |
| 52 Week Low | $1.36 | $3.72 |
| 52 Week High | $6.00 | $11.78 |
Technical Indicators
Market Signals| Indicator | BCG | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 45.40 |
| Support Level | $2.10 | $4.34 |
| Resistance Level | $2.37 | $4.77 |
| Average True Range (ATR) | 0.28 | 0.37 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 36.61 | 38.63 |
Price Performance
Historical ComparisonAbout BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.